Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ziman

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Letters|March 18, 2018
Melanoma circulating tumor cells: Benefits and challenges required for clinical applicationG Marsavela, C A Aya-Bonilla, M E Warkiani, et al.
Molecular Biology of the Cell|December 1, 1993
Subcellular localization of Cdc42p, a Saccharomyces cerevisiae GTP-binding protein involved in the control of cell polarityM Ziman, D Preuss, J Mulholland, et al.
Molecular and Cellular Biology|July 1, 1991
Mutational analysis of CDC42Sc, a Saccharomyces cerevisiae gene that encodes a putative GTP-binding protein involved in the control of cell polarityM Ziman, J M O'Brien, L A Ouellette, et al.
The International Journal of Biochemistry & Cell Biology|June 3, 1998
Pax7 includes two polymorphic homeoboxes which contain rearrangements associated with differences in the ability to regenerate damaged skeletal muscle in adult miceP H Kay, D Harmon, S Fletcher, et al.
Journal of Cellular Physiology|January 1, 1993
Role of receptor complexes in resistance or sensitivity to growth inhibition by TGF beta in intestinal epithelial cell clonesK M Mulder, P R Segarini, S L Morris, et al.
Gene|January 3, 1997
Variation in the methylation profile and structure of Pax3 and Pax7 among different mouse strains and during expressionP H Kay, D Harmon, S Fletcher, et al.
Scientific Reports|November 3, 2020
Stopping targeted therapy for complete responders in advanced BRAF mutant melanomaL Warburton, T M Meniawy, L Calapre, et al.
Growth Factors (Chur, Switzerland)|January 1, 1991
Differences in the biological activities of transforming growth factor-beta and platelet-derived growth factor in vivoY Ogawa, G A Ksander, B M Pratt, et al.
The British Journal of Dermatology|September 28, 2012
Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progressionA L Reid, M Millward, R Pearce, et al.
Nature Genetics|May 1, 1996
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyriaP N Meissner, T A Dailey, R J Hift, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Letters|March 18, 2018
Melanoma circulating tumor cells: Benefits and challenges required for clinical applicationG Marsavela, C A Aya-Bonilla, M E Warkiani, et al.
Molecular Biology of the Cell|December 1, 1993
Subcellular localization of Cdc42p, a Saccharomyces cerevisiae GTP-binding protein involved in the control of cell polarityM Ziman, D Preuss, J Mulholland, et al.
Molecular and Cellular Biology|July 1, 1991
Mutational analysis of CDC42Sc, a Saccharomyces cerevisiae gene that encodes a putative GTP-binding protein involved in the control of cell polarityM Ziman, J M O'Brien, L A Ouellette, et al.
The International Journal of Biochemistry & Cell Biology|June 3, 1998
Pax7 includes two polymorphic homeoboxes which contain rearrangements associated with differences in the ability to regenerate damaged skeletal muscle in adult miceP H Kay, D Harmon, S Fletcher, et al.
Journal of Cellular Physiology|January 1, 1993
Role of receptor complexes in resistance or sensitivity to growth inhibition by TGF beta in intestinal epithelial cell clonesK M Mulder, P R Segarini, S L Morris, et al.
Gene|January 3, 1997
Variation in the methylation profile and structure of Pax3 and Pax7 among different mouse strains and during expressionP H Kay, D Harmon, S Fletcher, et al.
Scientific Reports|November 3, 2020
Stopping targeted therapy for complete responders in advanced BRAF mutant melanomaL Warburton, T M Meniawy, L Calapre, et al.
Growth Factors (Chur, Switzerland)|January 1, 1991
Differences in the biological activities of transforming growth factor-beta and platelet-derived growth factor in vivoY Ogawa, G A Ksander, B M Pratt, et al.
The British Journal of Dermatology|September 28, 2012
Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progressionA L Reid, M Millward, R Pearce, et al.
Nature Genetics|May 1, 1996
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyriaP N Meissner, T A Dailey, R J Hift, et al.
Pageof 4